Infliximab for severe gastrointestinal bleeding in Crohn's disease

Inflammatory Bowel Diseases

Volumn 15, Issue 3, 2009, Pages 483-484

  Ando, Yugo ^a   Matsushita, Mitsunobu ^a   Kawamata, Seiji ^a   Shimatani, Masaaki ^a   Fujii, Toshihito ^a   Okazaki, Kazuichi ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; INFLIXIMAB; MESALAZINE; PREDNISOLONE; GASTROINTESTINAL AGENT; MONOCLONAL ANTIBODY;

ABDOMINAL PAIN; ABDOMINAL TENDERNESS; ADOLESCENT; ALBUMIN BLOOD LEVEL; ANGIOGRAPHY; CASE REPORT; COLONOSCOPY; CROHN DISEASE; DRUG DOSE INCREASE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATOCHEZIA; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HEMORRHAGIC SHOCK; HUMAN; LETTER; LEUKOCYTE COUNT; MAINTENANCE THERAPY; PARENTERAL NUTRITION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGMOID; SINGLE DRUG DOSE; ULCERATIVE COLITIS; FOLLOW UP; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION;

ADOLESCENT; ANTIBODIES, MONOCLONAL; COLONOSCOPY; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HUMANS; INFUSIONS, INTRAVENOUS; SEVERITY OF ILLNESS INDEX;

EID: 66149140656     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20635     Document Type: Letter

References (6)

1. Papi C, Gili L, Tarquini M, et al. Infliximab for severe recurrent Crohn's disease presenting with massive gastrointestinal hemorrhage. J Clin Gastroenterol. 2003;36:238-241.
2. Tsujikawa T, Nezu R, Andoh A, et al. Infliximab as a possible treatment for the hemorrhagic type of Crohn's disease. J Gastroenterol. 2004;39:284-287.
3. Belaiche J, Louis E. Severe lower gastrointestinal bleeding in Crohn's disease: successful control with infliximab. Am J Gastroenterol. 2002;97:3210-3211.
4. Pardi DS, Loftus EV Jr, Tremaine WJ, et al. Acute major gastrointestinal hemorrhage in inflammatory bowel disease. Gastrointest Endosc. 1999-49:153-157.
5. D'Haens G, Van Deventer S, Van Hogezand R, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial, Gastroenterology. 1999;116:1029-1034.
6. Blonski W, Lichtenstein GR. Safety of biologic therapy. Inflamm Bowel Dis. 2007; 13: 769-796.